RU2409363C9 - Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций - Google Patents

Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций Download PDF

Info

Publication number
RU2409363C9
RU2409363C9 RU2009134872/15A RU2009134872A RU2409363C9 RU 2409363 C9 RU2409363 C9 RU 2409363C9 RU 2009134872/15 A RU2009134872/15 A RU 2009134872/15A RU 2009134872 A RU2009134872 A RU 2009134872A RU 2409363 C9 RU2409363 C9 RU 2409363C9
Authority
RU
Russia
Prior art keywords
dim
pluronic
pharmaceutical composition
compositions
diindolylmethane
Prior art date
Application number
RU2009134872/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2409363C1 (ru
Inventor
Всеволод Иванович Киселев
Ирина Геннадьевна Васильева
Original Assignee
Всеволод Иванович Киселев
Ирина Геннадьевна Васильева
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to RU2009134872/15A priority Critical patent/RU2409363C9/ru
Application filed by Всеволод Иванович Киселев, Ирина Геннадьевна Васильева filed Critical Всеволод Иванович Киселев
Priority to PCT/RU2010/000487 priority patent/WO2011034465A1/ru
Priority to KR1020127010004A priority patent/KR20120078722A/ko
Priority to UAA201204644A priority patent/UA102187C2/ru
Priority to CN2010800524064A priority patent/CN102711755A/zh
Priority to EA201200185A priority patent/EA020932B1/ru
Priority to CA2774645A priority patent/CA2774645C/en
Priority to EP10817500.1A priority patent/EP2478904B1/en
Priority to US13/377,261 priority patent/US8791150B2/en
Priority to JP2012529708A priority patent/JP2013505233A/ja
Application granted granted Critical
Publication of RU2409363C1 publication Critical patent/RU2409363C1/ru
Publication of RU2409363C9 publication Critical patent/RU2409363C9/ru
Priority to US14/310,768 priority patent/US20140303225A1/en

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
RU2009134872/15A 2009-09-18 2009-09-18 Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций RU2409363C9 (ru)

Priority Applications (11)

Application Number Priority Date Filing Date Title
RU2009134872/15A RU2409363C9 (ru) 2009-09-18 2009-09-18 Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций
KR1020127010004A KR20120078722A (ko) 2009-09-18 2010-09-07 디인돌리메탄의 경구 투여용 약학 조성물
UAA201204644A UA102187C2 (ru) 2009-09-18 2010-09-07 Фармацевтическая композиция для пероральной доставки дииндолилметана
CN2010800524064A CN102711755A (zh) 2009-09-18 2010-09-07 用于口服3,3’-二吲哚基甲烷的药物组合物
PCT/RU2010/000487 WO2011034465A1 (ru) 2009-09-18 2010-09-07 Фармацевтическая композиция для пероральной доставки дииндолилметана
EA201200185A EA020932B1 (ru) 2009-09-18 2010-09-07 Фармацевтическая композиция для пероральной доставки дииндолилметана
CA2774645A CA2774645C (en) 2009-09-18 2010-09-07 Pharmaceutical composition for peroral administration of 3,3'-diindolylmethane
EP10817500.1A EP2478904B1 (en) 2009-09-18 2010-09-07 A pharmaceutical composition for peroral administration of diindolylmethane
US13/377,261 US8791150B2 (en) 2009-09-18 2010-09-07 Pharmaceutical composition for peroral administration of diindolylmethane
JP2012529708A JP2013505233A (ja) 2009-09-18 2010-09-07 ３，３’−ジインドリルメタンの経口投与用医薬組成物
US14/310,768 US20140303225A1 (en) 2009-09-18 2014-06-20 Pharmaceutical composition for peroral administration of 3,3'-diindolylmethane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2009134872/15A RU2409363C9 (ru) 2009-09-18 2009-09-18 Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций

Publications (2)

Publication Number Publication Date
RU2409363C1 RU2409363C1 (ru) 2011-01-20
RU2409363C9 true RU2409363C9 (ru) 2013-12-10

Family

ID=43758874

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009134872/15A RU2409363C9 (ru) 2009-09-18 2009-09-18 Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций

Country Status (10)

Country Link
US (2) US8791150B2 (enExample)
EP (1) EP2478904B1 (enExample)
JP (1) JP2013505233A (enExample)
KR (1) KR20120078722A (enExample)
CN (1) CN102711755A (enExample)
CA (1) CA2774645C (enExample)
EA (1) EA020932B1 (enExample)
RU (1) RU2409363C9 (enExample)
UA (1) UA102187C2 (enExample)
WO (1) WO2011034465A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2564438C1 (ru) * 2014-07-07 2015-09-27 Закрытое акционерное общество "ИльмиксГрупп" (далее - ЗАО "ИльмиксГрупп") Способ лечения простатической интраэпителиальной неоплазии (пин)
RU2741577C2 (ru) * 2016-09-15 2021-01-27 Скинтек Лайф Сайенс Лимитед Сублингвальное или буккальное введение dim для лечения заболеваний кожи

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201105050D0 (en) * 2011-03-25 2011-05-11 Iiaa Ltd Pharmaceutical agent
RU2494733C1 (ru) 2012-10-16 2013-10-10 Всеволод Иванович Киселев Фармацевтическая композиция на основе фитонутриентов с повышенной биодоступностью, обладающая противоопухолевой активностью, и способ ее получения (варианты)
WO2015042170A1 (en) 2013-09-17 2015-03-26 Wayne State University Compositions and uses of combinations of dim-related indoles and selected anti-androgen compounds
ITMI20131924A1 (it) * 2013-11-20 2015-05-21 Cosmo Technologies Ltd Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection emulsioni o microemulsioni per uso nella resezione mucosale endoscopica e/o dissezione submucosale endoscopica
WO2016164770A1 (en) 2015-04-10 2016-10-13 Bioresponse, L.L.C. Self-emulsifying formulations of dim-related indoles
WO2017001979A1 (en) * 2015-06-27 2017-01-05 Reform Bio Inc. Diindolyl methane compositions, formulations and use thereof
GB2565492A (en) * 2016-05-16 2019-02-13 Nordic Labs Ltd Means for treating sexually-transmitted infectious diseases
JP6644017B2 (ja) * 2017-03-30 2020-02-12 長弘生物科技股▲ふん▼有限公司 ブチリデンフタリドの用途、その使用方法及びそれを使用して医薬組成物を製造する方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6416793B1 (en) * 2000-07-11 2002-07-09 Bioresponse, L.L.C. Formulations and use of controlled-release indole alkaloids
RU2318509C2 (ru) * 2006-02-10 2008-03-10 Всеволод Иванович Киселев Твердая лекарственная форма дииндолилметана для лечения неопластических заболеваний

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US7384971B2 (en) * 1999-09-23 2008-06-10 Bioresponse L.L.C. Phytochemicals for the treatment of cervical dysplasia
US8080577B2 (en) * 2004-05-06 2011-12-20 Bioresponse, L.L.C. Diindolylmethane formulations for the treatment of leiomyomas
AU2005311782A1 (en) * 2004-11-30 2006-06-08 Myriad Genetics, Inc. Therapeutic formulations
US8142806B2 (en) * 2008-03-10 2012-03-27 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6416793B1 (en) * 2000-07-11 2002-07-09 Bioresponse, L.L.C. Formulations and use of controlled-release indole alkaloids
RU2318509C2 (ru) * 2006-02-10 2008-03-10 Всеволод Иванович Киселев Твердая лекарственная форма дииндолилметана для лечения неопластических заболеваний

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2564438C1 (ru) * 2014-07-07 2015-09-27 Закрытое акционерное общество "ИльмиксГрупп" (далее - ЗАО "ИльмиксГрупп") Способ лечения простатической интраэпителиальной неоплазии (пин)
RU2741577C2 (ru) * 2016-09-15 2021-01-27 Скинтек Лайф Сайенс Лимитед Сублингвальное или буккальное введение dim для лечения заболеваний кожи

Also Published As

Publication number Publication date
WO2011034465A1 (ru) 2011-03-24
KR20120078722A (ko) 2012-07-10
US20130065933A1 (en) 2013-03-14
JP2013505233A (ja) 2013-02-14
EP2478904A1 (en) 2012-07-25
CA2774645A1 (en) 2011-03-24
US8791150B2 (en) 2014-07-29
CA2774645C (en) 2018-10-09
US20140303225A1 (en) 2014-10-09
UA102187C2 (ru) 2013-06-10
CN102711755A (zh) 2012-10-03
EP2478904B1 (en) 2016-03-16
EA201200185A1 (ru) 2012-07-30
EP2478904A4 (en) 2013-03-06
EA020932B1 (ru) 2015-02-27
RU2409363C1 (ru) 2011-01-20

Similar Documents

Publication Publication Date Title
RU2409363C9 (ru) Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций
JP7627302B2 (ja) パルボシクリブの固形剤形
JP5726067B2 (ja) 難透過性医薬品活性成分のための改善された製剤
TW201427659A (zh) 恩雜魯它脈（ｅｎｚａｌｕｔａｍｉｄｅ）之調和物
US8586091B2 (en) Pharmaceutical composition comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-quinazolinamine
AU2006257428B2 (en) Oral solid pharmaceutical formulation of the tubulin inhibitor indibulin
WO2019149884A1 (en) Use of colchicine to inhibit tumor growth and metastases
Zayed et al. Novel water-soluble lubricant for the preparation of tiemonium methylsulfate fast-dissolving tablets
Vageesh et al. Preparation and In Vitro Charactersation of Fast Disintigrating Tablets of Cimetidine
Palekar-Shanbhag et al. TASTE-NUMBNESS MASKED ODT OF RILUZOLE INTERNAL TERNARY SOLID DISPERSION
WO2021089715A1 (en) Use of colchicine in the treatment and prevention of lung cancer
Gupta et al. Formulation Development and Evaluation of Oral Dispersible Tablet of Levocetirizine Dihydrochloride, Paracetamol and Montelukast Sodium

Legal Events

Date Code Title Description
TK4A Correction to the publication in the bulletin (patent)

Free format text: AMENDMENT TO CHAPTER -FG4A- IN JOURNAL: 2-2011 FOR TAG: (72)

PC41 Official registration of the transfer of exclusive right

Effective date: 20110523

TH4A Reissue of patent specification
QB4A Licence on use of patent

Free format text: LICENCE

Effective date: 20131227

PD4A Correction of name of patent owner